Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
0.00%
)
US TECH 100
25,973.60
(
0.78%
)
Dow Jones
49,447.43
(
0.00%
)
Brent Oil
95.73
(
0.76%
)
Bitcoin
78,289.15
(
2.57%
)
News Focus
News Focus
Post# of 822372
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

thermo

Send PM Follow Ignore
Followers 197
Posts 735
Boards Moderated 0
Alias Born 10/27/2016

thermo

Re: themurphman post# 535579

Saturday, 11/19/2022 1:05:52 PM

Saturday, November 19, 2022 1:05:52 PM

Post# of 822372
Not that concerned. If NW can't work around any IP then they are the natural licensee anyway. UCLA isn't going to into the pharma biz and having IP around Muricidencel and FlaskWorks is critical.

If what we're hearing on combinations holds up to investigation, then the negotiations might be between big pharma and UCLA.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News